Status: Recruiting
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
Open-label, randomized multicenter phase III non-inferiority study
Participants needed: 274
Trial details
Phase: Phase 3Age: 18-70Biological sex: AllType: InterventionalSponsor: Gruppo Italiano Malattie EMatologiche dell'AdultoUpdated: Apr 29, 2025Locations: 46
Eligibility criteria
Patients with newly diagnosed higher-risk MDS, including IPSS Intermediate-2 and... [+6]
Acute myeloid leukaemia with >20% blasts in BM or peripheral blood (PB); [+11]